Since compound C1 also can activate mTORC1 (Song et al., 2016; Figure S1J) and AKT (Figure S5), the pro‐survival signaling triggered by TFEB activation may also contribute to the neuroprotective effects of C1 in AD models. Here, AKT1 is linked to Alzheimer disease.